ALZN 8-K/A 2026-11-10

Alzamend Neuro, Inc. (ALZN) 8-K/A dated 2026-11-10 — accession 0001214659-26-013930.

Alzamend Neuro, Inc. (ALZN) is a biotechnology company listed on US.

Alzamend Neuro, Inc. filed a 8-K/A on 2026-11-10. Accession 0001214659-26-013930.

This 8-K/A covers: Material agreement (Item 1.01), Unregistered share sale (Item 3.02), Bylaws or fiscal year change (Item 5.03), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for ALZN is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The ALZN SEC hub lists recent forms. The stock page is the research view.